| |
| |
|
| Insider
Information: |
Oncology Impact Fund (cayman) Management L.p. |
| Relationship: |
10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
4,484,728 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
4,484,728 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Iteos Therapeutics, Inc. |
ITOS |
10% Owner |
2020-07-28 |
0 |
2022-01-05 |
4,484,728 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2022-01-05 |
4 |
S |
$42.03 |
$1,275,484 |
I/I |
(30,347) |
4,484,728 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2022-01-04 |
4 |
S |
$42.05 |
$9,176,850 |
I/I |
(215,122) |
4,515,075 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-12-07 |
4 |
AS |
$33.15 |
$1,081,697 |
I/I |
(32,558) |
4,730,197 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-12-06 |
4 |
AS |
$32.35 |
$556,766 |
I/I |
(17,083) |
4,762,755 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-12-03 |
4 |
AS |
$34.68 |
$1,173,965 |
I/I |
(33,749) |
4,779,838 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-11-29 |
4 |
AS |
$34.46 |
$598,543 |
I/I |
(17,356) |
4,953,360 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-11-26 |
4 |
AS |
$35.49 |
$758,282 |
I/I |
(21,210) |
4,970,716 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-11-24 |
4 |
AS |
$35.20 |
$2,206,510 |
I/I |
(60,808) |
4,991,926 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-11-23 |
4 |
AS |
$36.21 |
$1,212,340 |
I/I |
(33,476) |
5,052,734 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-11-22 |
4 |
AS |
$37.16 |
$1,325,817 |
I/I |
(35,333) |
5,086,210 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-11-17 |
4 |
AS |
$0.00 |
$0 |
I/I |
(15,671) |
5,121,543 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-10-18 |
4 |
AS |
$27.14 |
$280,085 |
I/I |
(10,320) |
5,137,214 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-10-15 |
4 |
AS |
$27.53 |
$505,300 |
I/I |
(18,295) |
5,147,534 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-10-14 |
4 |
AS |
$27.30 |
$1,248,129 |
I/I |
(45,719) |
5,165,829 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-10-13 |
4 |
AS |
$27.13 |
$950,174 |
I/I |
(35,023) |
5,211,548 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-10-12 |
4 |
AS |
$27.09 |
$386,303 |
I/I |
(14,260) |
5,246,571 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-10-11 |
4 |
AS |
$27.24 |
$2,225,072 |
I/I |
(81,684) |
5,260,831 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-10-08 |
4 |
AS |
$27.01 |
$91,834 |
I/I |
(3,400) |
5,342,515 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-10-07 |
4 |
AS |
$27.00 |
$51,894 |
I/I |
(1,922) |
5,345,915 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-10-04 |
4 |
AS |
$27.06 |
$937,873 |
I/I |
(34,659) |
5,347,837 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-10-01 |
4 |
AS |
$27.00 |
$309,717 |
I/I |
(11,471) |
5,382,496 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-09-30 |
4 |
AS |
$27.00 |
$103,572 |
I/I |
(3,836) |
5,393,967 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-09-28 |
4 |
AS |
$27.00 |
$868,158 |
I/I |
(32,154) |
5,397,803 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-09-27 |
4 |
AS |
$27.09 |
$527,036 |
I/I |
(19,455) |
5,429,957 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-09-24 |
4 |
AS |
$27.81 |
$228,626 |
I/I |
(8,221) |
5,449,412 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
